Guide to DI (Exam 1) Flashcards
Drug Information
Facts or advice on drugs
Drug Information Center
A physical location where pharmacists have the resources to provide drug information
Drug Information Service
A professional service providing drug information
Optimal drug development requires a balance between achieving ________ and eliciting desired ______.
therapeutic concentrations (PK)
therapeutic effects (PD)
Pharmacokinetics (PK)
Body on drug
ADME
Pharmacodynamics (PD)
Drug on body
Drug-receptor interactions
MOA
Dose-response relationship
Drug Development Stages
Pre-clinical
Phase 1
Phase 2
Phase 3
FDA approval
Phase 4
Pre-clinical testing
In vitro/vivo studying on cells and animals
Phase 1
Safety and tolerability of drug in 20-100 healthy humans
Phase 2
Effect of drug in 100-200 patients with target disease
Efficacy and dosing
What percent of drugs will enter phase 3?
25%
Phase 3
Effect of drug in a few thousand patients with target disease
Double-blind design
Applying for FDA Approval
NDA reviewed by FDA and approved/denied
Phase 4
Post-marketing monitoring
MedWatch
Collects reports about unexpected side effects, quality issues, medication errors, and therapeutic failures
Voluntary
FAERS
FDA Adverse Event Reporting System
Information on drug and biologic reports
VAERS
CDC Vaccine Adverse Event Reporting System
Prescribing Information (PI)
Package insert, prescribing information, prescription drug labeling, product label
NO “off-label” indications
Which phase of FDA drug development is most concerned with human pharmacodynamic parameters of the drug?
Phase 1
What is the primary objective of Phase 4 clinical trials in FDA drug development?
Gather additional safety data in real-world setting
Black Box Warning (BBW)
Contraindications
Warnings and Precautions
Adverse Reactions
Drugs with serious safety concerns may require enrollment in _____ to manage.
Risk Evaluation and Mitigation Strategies (REMS)
Risk Evaluation and Mitigation Strategies (REMS)
FDA required safety programs for meds with specific serious adverse effects
Ex. Clozapine REMS
Adverse Drug Event
Harm caused by appropriate OR inappropriate use of drug
includes adverse drug reactions
Adverse Drug Effect
potentially harmful effect due to use of drug discovered during clinical exam or lab value
Adverse Drug Reaction
Harm directly caused by drug under appropriate use and normal conditions
Common Terminology Criteria for Adverse Events (CTCAE)
System used for reporting and grading severity of adverse events
Grade 1-5
Grade 1 Mild
Asymptomatic or mild symptoms
No intervention
Grade 2 Moderate
Minimal, local, noninvasive intervention
Limits daily activities
Grade 3 Severe
Medically significant but not life threatening
Hospitalization required
Grade 4 Life-threatening
Urgent intervention
ICU
Grade 5
Death :o
Full Prescribing Information (PI)
Drug Interactions
Drug Abuse and Dependence
Overdosage
References
Drug Interactions vs Drug Incompatibilities
Interactions - in body
Incompatibility - in vitro
Electronic “Drug ID” Tool
Drug identification
Enter letters and numbers from pill
Drug Instability
Eventual drug incompatibility or degradation
Where clinical trials can register to provide the public with transparent information?
ClinicalTrials.gov
Where to find PI?
DailyMed
Product Website
Manufacturer’s Website
Drugs@FDA
OTC Monographs@FDA
Paper label attachment
NO GOOGLE
Types of DI Resources
Primary
Secondary
Tertiary
Tertiary Resource
Summaries of available info
Secondary Resource
Databases which link primary sources
Primary Resource
Present new/original material
Which resource is the best starting point for gathering information?
Tertiary
Drug Monograph
Structured document that reviews major features of a drug product
Limited to FDA-approved info
Monograph vs monogram
idk just remember to look for the word monoGRAPH probs a true/false question
edit: monogram is a t-shirt print with initials
Drug Monograph Body Contents
Indications (off-label as well)
Guidelines
Cost comparison
Drug Monograph Sources
PI, Package Insert, NDA, ANDA
Drug Compendia
sources for use in determining medically-accepted indication of drugs and biologicals used off-label in an anti-cancer chemo regimen
Types of Compendia
AHFS DI
Micromedex
Lexicomp
Clinical Pharmacy
NCCN Drugs and Biologics
AHFS DI
“Need to know” about drugs
Micromedex
Summary info
Links to REDBOOK and Trissel’s
Lexicomp/drug
Quick look up
Links to AHFS DI, Briggs, and Trissel’s
Clinical Pharmacology
“Find by” feature
Links to AHFS DI, Harriet Lane, Trissel’s
NCCN Drugs and Biologics
Decision-making for patients’s w cancer
Which compendium provides access to Harriet Lane Handbook?
Clinical Pharmacology
Disease Oriented Resources for Therapeutics
Koda-Kimble and Young’s
Applied Therapeutics
Pharmacotherapy (Dipiro)
Disease Oriented Resources for Symptoms and Diagnosis
Goldman’s
Harrison’s
Disease Oriented Resources for General Background Websites
Pharmacist’s Letter
Dynamed / dynamedex
UpToDate
Epocrates
Merck Manual
Medscape
Disease Oriented Resources for Pharmacology
Brody’s
Basic & Clinical (Katzung)
Goodman $ Gilman’s
Specialty Resources for Compounding and IV Stability
King Guide
Trissel’s
IJPC
Compounding Today
Remington
US Pharmacopoeia
Specialty Resources for Drug Shortages
ASHP and FDA Drug shortages
Specialty Resources for OTC
Handbook of Nonprescription Drugs
OTC Monographs@FDA
Specialty Resources for Drug Interactions
Stockley’s
Liverpool
Hansten and Horn
Specialty Resources for ADRs
FAERS and VAERS
MedWatch
Meyler’s
Reactions Weekly
Side effects of Drugs Annual
Specialty Resources for Toxicology
Posion Control Center
PoisinDex
Lexi-Tox
ToxEd
Goldfrank’s
Casarett & Doull’s
Specialty Resources for Pharmaceutical Industry
Phact MI
Is IV compatibility the same as absence of drug interaction?
NO!
Number for poison control
1-800-222-1222
Specialty Resources for Veterinary
Merck Manual
Plumb’s
Specialty Resources for Pediatrics
Harriet Lane
Neofax
TeddyBear
Specialty Resources for Pharmacogenomics
Pharmacogenomics and Lab Tests
CPIC
PharmGKB
RxPgx
Specialty Resources for Pregnancy/Lactation
Brigg’s
LactMed
Specialty Resources for Geriatrics
Beers Criteria
Specialty Resources for infectious Disease
Sanford Guide
Specialty Resources for Immunizations
CDC Immunization Schedule
Immunization Action Coalition
Specialty Resources for Drug Information
Drug Information
RxList.com
Specialty Resources for International
Martindale
Index Nominum
WHO
European Med Agency
Specialty Resources for Herbal Therapies
Natural Medicines Database
Examine.com
NIH Office
About Herbs
Specialty Resources for Enteral Administration
Handbook of Drug Administration via Enteral Feeding Tubes
Green Book
Animal Products
Orange Book
Therapeutic Equivalence
Purple Book
Biosimilars
Pink Book
Vaccine-Preventable Diseases
REDBOOK
Pricing Info
American Academy of Pediatrics Red Book
Pediatric Infectious Disease
Yellow Book
Travelers’ Health Info
What do most health care professionals use to search information?
Specific medication website/apps
Systematic Approach to Answering DI Questions
- Receive
- Expand
- Classify
- Search
- Evaluate
- Formulate
- Communicate
- Follow-up
Why does complexity matter when searching databases?
Obvious search terms for low-mid complexity
Specific search terms for mid-high complexity
Secondary resource strategies
Select appropriate search terms
Determine what filters need to be placed
Assess primary literature by
Validity of journal
Date published
Target audience
Author credentials
Formulating a response includes
Patient factors
Disease factors
Medication factors
Background info
Special circumstances
Analysis vs. Synthesis
Analysis: breaking down into component parts
Synthesis: Process of combining varied and diverse ideas into a coherent whole
When providing a response
List all resources searched
Provide facts
Summarize
Which reference style do we use?
AMA style
AMA Style
Author(s),Title, Journal name Year;vol(issue No.):inclusive pages. DOI
Citing package insert
Medication name. Package insert. Publisher; Year. Accessed month, day, year. doi/url